Browse drugs

…T1D, emphasis should be placed on reliable carbohydrate access, insulin and CGM affordability, and hypoglycemia prevention. For T2D, in…

…: self-reported physician diagnosis of diabetes, current use of insulin or oral glucose-lowering medications, fasting plasma glucose≥12…

…h later hippocampal atrophy. Initial treatment with insulin and levetiracetam led to significant recovery. This case underscores hyperosmolar…

…iated during follow-up—may still exist. At baseline, the use of sodium–glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and glucagon-like pept…

…le in 30% (3/10) of FCVs compared with 83% (10/12) of non-FCVs; insulin was available in primary care in 50% (5/10) of FCVs compared wi…

…ceiving hormone-modulating medications (including testosterone, somatropin, adrenal cortical steroids, and thyroid hormones) were excluded…

…th diabetes (n=23), 14 (60.9%) are on insulin, 9 (39.1%) are on metformin, 7 (30.4%) are on SGLT2 inhibitors,5 (14.7%) are on sulfonylure…

…ical analysis showed that the vial contained insulin instead of semaglutide, therefore leading to severe hypoglycaemia. This case highlight…

…4% both. Mean age: 57.1±10.2 years, 72.2% female and 76% obese. Renin angiotensin aldosterone system inhibitors were prescribed in 32.3%, and only 1.2% used insulin despite a …

…the analysis. The median PDC for any DM drug, oral DM drugs and insulin during the observation period was 20.3%, 16.8% and 0%, respecti…

…and progression to combination therapy (HR=3.22 (3.04–3.41)) or insulin (HR=3.21 (2.89–3.55)).Conclusion Individuals with T2D who show …

…eatment strategy against early development of T1D could involve flagellin to increase TLR5 expression, and thereby naturally inhibiting T…